tecnet equity
Lower Austrian venture capital fund and technology-transfer vehicle — 20+ years, over EUR 50 million in fund volume, bridging research and market.
Vitality Radar
Pillar Analysis
Strategic Assessment
Strategic Vector
tecnet equity presents as a publicly backed early-stage venture capital and technology-transfer platform focused on turning research into regional startup outcomes, especially in deep tech, life sciences, and industrial technology.[1][3][16] Its strategic posture is strongly network- and ecosystem-driven rather than product-led, with a clear Lower Austria anchor and a mandate tied to spin-offs and commercialization.[9][15][16]
Efficiency Ratio
The organization appears relatively lean, with a small staff base managing a venture portfolio and technology-transfer mandate, suggesting high leverage per employee but limited operational depth compared with larger funds.[3][4][15][18]
Evidence Signals
Company website states it invests know-how and capital to bridge research to startup success, indicating a technology-transfer and venture-funding model.
View sourceLinkedIn profile shows a privately held company founded in 2002 with 11-50 employees and about 1,405 followers.
View sourceBusiness directory sources describe tecnet equity as the Technologiefinanzierungsgesellschaft of Lower Austria, focused on venture capital, patent and technology commercialization, and startup support.
View sourceIndependent fund profile reports a portfolio of 26 active companies and 53 total investments, indicating sustained investment activity.
View sourceHEInnovate and tecnet equity are referenced together in a higher-education and entrepreneurship initiative, signaling ecosystem partnership activity.
View sourceImpressum and register data confirm a formal legal entity with company register number 225872s and headquarters in St. Pölten.
View sourcePublic directory listings show a small operating footprint, with staff counts around 11 or 1-10 employees depending on the source.
View source- About
- tecnet equity, based in St. Pölten, Lower Austria, 11 to 50 staff. An Austrian venture capital fund investing in high-tech startups with significant growth potential, positioning itself as a bridge between research and market and pairing capital with its own expertise. It has operated for more than two decades, reports fund volume above EUR 50 million, and cites over 400 measures under its r2v next technology-transfer programme. TWO ARMS. Venture Capital, including SAFE instruments and a portfolio; and Technology Transfer, running training, workshops, an Innovation Award with accent, a From Research to Value podcast, and the r2v next and m-power net programmes working with Lower Austrian higher education institutions on IP strategy and commercialisation. PORTFOLIO AND DEALS include VALANX Biotech (EUR 3 million for an antibody-drug conjugate, following EUR 2.3 million growth financing), Sipfront (EUR 1.8 million with Airbridge Equity Partners, after EUR 1.3 million earlier, for voice-AI quality assurance), Circly (AI), PROPCORN AI (EUR 200,000, proptech), Nexufend (network security, from ex-Safing founders), Sarcura (EUR 7 million seed plus, cell therapy), Greenwood Power (EUR 5.1 million with eQventure) and Shopstory (e-commerce). ECOSYSTEM ACTIVITY: sponsor of the AIT Poster Award, participant in the i2b business plan contest (around 800 entries a year), the EY Scale-up Award, CPI Demo Day at FH Wiener Neustadt, and Innovation Corner exhibitions at the Vienna Museum of Science and Technology.
- Relevancy
- Lower Austria's venture capital and technology-transfer arm, and the route into the ESA Phi-Lab at Vienna Airport — one of only two aerospace startup pipelines in the country. Relevant less as a drone investor than as the institution that turns Austrian research into companies.
- Tags
- #venturecapital #technologytransfer #LowerAustria #spinoffs #r2vnext #ESAPhiLab #deeptech #IPstrategy